Advertisement

Unspecific Mesenchymal Reaction in Bone Marrow in Patients with Hogdkin’s Disease

  • A. Georgii
  • K. F. Vykoupil
Part of the Recent Results in Cancer Research / Fortschritte der Krebsforschung / Progrès dans les recherches sur le cancer book series (RECENTCANCER, volume 46)

Summary

For 72 patients with Hodgkin’s disease with no evidence of bone marrow infiltration, the intensity of tumour-myelopathy is compared to the histological classification of lymphnodes (Rye classification), clinical findings and therapy. Tumour-myelopathy is defined as a lesion of the haematopoetic parenchyma and vascular mesenchyma which is thought to be a direct consequence of Hodgkin’s disease. These alterations were also seen in 24 other malignant lymphomas (lymphosarcomas, giant follicular lymphomas or germinoblastomas, and reticulosarcomas). In contrast, the bone marrow of patients with carcinomas and sarcomas did not demonstrate analogous lesions. Similarities and differences in the histological findings of tumour- myelopathy due to malignant lymphomas are discussed in relation to autoimmune diseases such as Lupus erythematosus and rheumatoid arthritis.

Keywords

Bone Marrow Malignant Lymphoma Bone Marrow Lesion Epitheloid Cell Bone Marrow Change 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Burkhardt, R.: The mesenchymal reaction of the bone marrow in hypersensitive mesenchymal diseases. Klin. Wsdir. 43, 1299 (1965);CrossRefGoogle Scholar
  2. 2.
    Chase, M. W.:Delayed-type hypersensitivity and the immunology of Hodgkin’s disease, with a parallel examination of sarcoidosis. Cancer Res. 26, 1097(1966).PubMedGoogle Scholar
  3. 3.
    Duhamel, G.: Les localisations a la moelle osseuse de la maladie de Hodgkin. Presse med. 79, 2305 (1971).PubMedGoogle Scholar
  4. 4.
    Farrer-brown, G., Bennett, M. H., Harrison, C. V., Millett, Y., Jelliffe, A. M.:The diagnosis of Hodgkin’s disease in surgically excised spleens. J. clin. Path. 25, 294 (1972).PubMedCrossRefGoogle Scholar
  5. 5.
    Glatstein, E., Guernsey, J. M., Rosenberg, S. A., Kaplan, H. S.: The value of laparatomy and splenectomy in the staging of Hodgkin’s disease. Cancer (Philad.) %24, 709 (1969).CrossRefGoogle Scholar
  6. 6.
    Graan, V., Pool, J. L., Mayer, K.: Comparative study of bone marrow aspiration and biopsy in patients with neoplastic disease. Cancer (Philad.) 19, 1898 (1966).CrossRefGoogle Scholar
  7. 7.
    Kadin, M. E., Donaldson, S. S., Dorfman, R. F.:Isolated granulomas in Hodgkin’s disease. New Engl. J. Med. 283, 859 (1970).PubMedCrossRefGoogle Scholar
  8. 8.
    Liao, K. T.: The superiority of histologic sections of aspirated bone marrow in malignant lymphomas. Cancer (Philad.) 27, 618 (1971).CrossRefGoogle Scholar
  9. 9.
    Oehlert, W., Dischler, W.:Unspezifische Mesenchymreaktion und Parendiymschäden der Leber bei Patienten mit Morbus Hodgkin. Dtsdi. med. Wschr. 97, 323 (1972).CrossRefGoogle Scholar
  10. 10.
    Rosenberg, S.A.:Hodgkin’s disease of the bone marrow. Cancer Res. 31, 1733 (1971).PubMedGoogle Scholar

Copyright information

© Springer-Verlag Berlin · Heidelberg 1974

Authors and Affiliations

  • A. Georgii
  • K. F. Vykoupil

There are no affiliations available

Personalised recommendations